LEACH JACOB STEVEN (SVP, Research & Development) purchased 5.8% of their position (18.20K shares) of DEXCOM INC on the open market
Open‑market purchase worth $1.00M — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/10/2025ACC: 0001093557-25-000284
Officer· SVP, Research & Development
Since Aug 2018
+18.20K
Net shares
Net buyer
$1.00M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
18.20K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15.70K
Price / share
$54.98
Trade value
$863.14K
% of position
5.0%
11/10/2025
313.50K→329.20K
Common Stock
Direct
Shares
+2.50K
Price / share
$55.43
Trade value
$138.56K
% of position
0.8%
11/10/2025
329.20K→331.70K
Total
Net shares
+18.20K
Net value
$1M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/10/2025 | P · Purchase | +15.70K | $54.98 | $863.14K | 5.0% | 313.50K | 329.20K |
| Common Stock Direct | 11/10/2025 | P · Purchase | +2.50K | $55.43 | $138.56K | 0.8% | 329.20K | 331.70K |
| Total | +18.20K | $1M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned47.30K
Total
47.30K indirect47.30K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 47.30K | Indirect |
| Total | 47.30K | 47.30K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported